Ownership history in MORGAN STANLEY · 5 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in EVOKE PHARMA INC (EVOK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 159,358 | +159,294 | +248896.9% | 0.00% | $792K | — |
| 2025 Q2 | UNCHANGED | 64 | — | 0% | 0.00% | $166 | — |
| 2025 Q1 | ADDED | 64 | +33 | +106.5% | 0.00% | $176 | — |
| 2024 Q4 | UNCHANGED | 31 | — | 0% | 0.00% | $137 | — |
| 2024 Q3 | INITIATED | 31 | — | — | 0.00% | $148 | — |